Results 141 to 150 of about 9,177 (185)

A marginal structural model for normal tissue complication probability. [PDF]

open access: yesBiostatistics
Tang TS   +4 more
europepmc   +1 more source

From standard to stratified: Modeling NTCP and EAR to personalize daily MV-CBCT in radiotherapy. [PDF]

open access: yesJ Appl Clin Med Phys
Tai DT   +9 more
europepmc   +1 more source

NTCP Oligomerization Occurs Downstream of the NTCP-EGFR Interaction during Hepatitis B Virus Internalization

Journal of Virology, 2021
Hepatitis B virus (HBV) infection is mediated by a specific interaction with sodium taurocholate-cotransporting polypeptide (NTCP), a viral entry receptor. Although the virus-receptor interactions are believed to trigger viral internalization into host cells, the exact molecular mechanisms of HBV internalization are not understood.
Samyong Park   +2 more
exaly   +3 more sources

NTCP opens the door for hepatitis B virus infection

Antiviral Research, 2015
A liver bile acids transporter, sodium taurocholate cotransporting polypeptide (NTCP, encoded by SLC10A1) was recently identified as a functional receptor for hepatitis B virus (HBV) and its satellite hepatitis D virus (HDV). NTCP-complemented human hepatoma HepG2 cells (HepG2-NTCP) were shown to support infection of HBV and HDV in vitro, providing a ...
Huan Yan, Jianhua Sui, Wenhui Li
exaly   +3 more sources

Clinical effects of NTCP‐inhibitor myrcludex B

Journal of Viral Hepatitis, 2021
AbstractWith extensive research on the pathogenesis and treatment of hepatitis B virus (HBV) and hepatitis D virus (HDV) infections, the current treatment of interferon and nucleoside or nucleotide analogues provides reasonable control of viral replication in chronic hepatitis B (CHB).
Dongliang Cheng   +3 more
openaire   +2 more sources

NTCP: a pharmacological target for multiple liver conditions

Gut, 2021
Despite major therapeutic advances to treat patients with chronic liver diseases, one target remains elusive in hepatology and this is the most important one: liver fibrosis. We can cure patients from chronic hepatitis C; we can vaccinate against hepatitis B virus and control chronic hepatitis B; we have new drugs to treat cholestatic liver diseases ...
Jordi Gracia-Sancho   +1 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy